WHO
REGULATORY UPDATE
Chiesi Caffeine citrate solution for infusion and oral solution prequalified
Published: 9/25/2026Detected: 7/10/2026
Summary preview
Adds a new WHO Prequalification Programme (PQP) product—caffeine citrate solution for infusion and oral solution (60 mg/3 mL) by Chiesi Farmaceutici S.p.A., Italy—to the prequalified list for treatment of apnea in…
Get the full analysis, free
Create a free account to see the complete summary, key takeaways, and why this matters for your products, and to get alerts like this by email.
Create free accountpediatrics
#WHO prequalification
#caffeine citrate
#preterm infants
#apnea of prematurity
#neonatal therapeutics
Official Source Document Source Verified
Access the original document directly from WHO.
More from WHO
- New Deadline for Submission: Request for Quotations (RFQ) from interested Notified Bodies - WHO Prequalification Assessment for Medical Devices10/2/2026
- PQT/AMD newsletter - Q3 2026, Issue 54 is now available10/2/2026
- PQ Webinar: Launch of WHO Prequalification of Medical Devices10/2/2026
- New EUL listing10/2/2026
- Prequalification of In Vitro Diagnostics: Scope Expansion10/2/2026